SGAM
Smith Group Asset Management Portfolio holdings
AUM
$1.53B
1-Year Return
38.67%
This Quarter Return
+16.87%
1 Year Return
+38.67%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$3.09B
AUM Growth
+$251M
(+8.8%)
Cap. Flow
-$137M
Cap. Flow
% of AUM
-4.46%
Top 10 Holdings %
Top 10 Hldgs %
29.06%
Holding
490
New
44
Increased
77
Reduced
236
Closed
43
Top Buys
| 1 |
Palo Alto Networks
PANW
|
$63.7M |
| 2 |
Dover
DOV
|
$30.2M |
| 3 |
Expeditors International
EXPD
|
$27.8M |
| 4 |
Deckers Outdoor
DECK
|
$27.6M |
| 5 |
Procter & Gamble
PG
|
$27.2M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$40.1M |
| 2 |
Home Depot
HD
|
$39.1M |
| 3 |
Apple
AAPL
|
$36.6M |
| 4 |
Adobe
ADBE
|
$35.5M |
| 5 |
Allison Transmission
ALSN
|
$34.1M |
Sector Composition
| 1 | Technology | 30.47% |
| 2 | Consumer Discretionary | 14.74% |
| 3 | Industrials | 14.02% |
| 4 | Healthcare | 13.44% |
| 5 | Financials | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVH
251
DELISTED
AVIANCA HOLDINGS S.A.
AVH
| $107K | ﹤0.01% |
26,016
-1,580
| -6% | -$6.5K |
|
252
TotalEnergies
TTE
$133B
| $104K | ﹤0.01% |
1,860
+90
| +5% | +$5.03K |
|
253
Apyx Medical
APYX
$74.1M
| $102K | ﹤0.01% |
16,200
-970
| -6% | -$6.11K |
|
254
James River Group
JRVR
$249M
| $102K | ﹤0.01% |
2,540
-8,700
| -77% | -$349K |
|
255
SunCoke Energy
SXC
$667M
| $102K | ﹤0.01% |
11,957
-710
| -6% | -$6.06K |
|
|
PES
256
DELISTED
Pioneer Energy Services Corp.
PES
| $101K | ﹤0.01% |
57,132
-188,098
| -77% | -$333K |
|
|
BPMC
257
DELISTED
Blueprint Medicines
BPMC
| $100K | ﹤0.01% |
1,250
-3,400
| -73% | -$272K |
|
258
Marcus & Millichap
MMI
$1.29B
| $99K | ﹤0.01% |
2,430
-8,200
| -77% | -$334K |
|
|
QIWI
259
DELISTED
QIWI PLC
QIWI
| $97K | ﹤0.01% |
6,730
-390
| -5% | -$5.62K |
|
260
Qualys
QLYS
$4.87B
| $96K | ﹤0.01% |
1,160
-4,000
| -78% | -$331K |
|
|
TOWR
261
DELISTED
Tower International, Inc.
TOWR
| $96K | ﹤0.01% |
4,561
-280
| -6% | -$5.89K |
|
262
Ultragenyx Pharmaceutical
RARE
$3.07B
| $95K | ﹤0.01% |
1,370
-4,600
| -77% | -$319K |
|
263
Rayonier Advanced Materials
RYAM
$397M
| $93K | ﹤0.01% |
6,892
-410
| -6% | -$5.53K |
|
|
GBT
264
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $89K | ﹤0.01% |
1,680
-3,180
| -65% | -$168K |
|
265
Central Pacific Financial
CPF
$841M
| $88K | ﹤0.01% |
3,040
-9,100
| -75% | -$263K |
|
266
Repligen
RGEN
$7.01B
| $86K | ﹤0.01% |
1,456
-3,500
| -71% | -$207K |
|
267
Emergent Biosolutions
EBS
$404M
| $85K | ﹤0.01% |
1,690
-4,584
| -73% | -$231K |
|
|
RDS.B
268
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $84K | ﹤0.01% |
1,313
+60
| +5% | +$3.84K |
|
|
PFC
269
DELISTED
Premier Financial Corp. Common Stock
PFC
| $81K | ﹤0.01% |
2,822
-180
| -6% | -$5.17K |
|
270
Ligand Pharmaceuticals
LGND
$3.25B
| $79K | ﹤0.01% |
1,010
-3,046
| -75% | -$238K |
|
271
Brady Corp
BRC
$3.86B
| $78K | ﹤0.01% |
1,680
-13,400
| -89% | -$622K |
|
272
Home Bancorp
HBCP
$440M
| $78K | ﹤0.01% |
2,340
-130
| -5% | -$4.33K |
|
273
Acadia Pharmaceuticals
ACAD
$4.26B
| $76K | ﹤0.01% |
2,840
-8,800
| -76% | -$235K |
|
274
PetMed Express
PETS
$63M
| $75K | ﹤0.01% |
3,310
-15,529
| -82% | -$352K |
|
275
Zumiez
ZUMZ
$366M
| $75K | ﹤0.01% |
3,020
-180
| -6% | -$4.47K |
|